Skip to main content
Orion Oyj logo

Orion Oyj — Investor Relations & Filings

Ticker · ORNAV ISIN · FI0009014377 LEI · 74370029VAHCXDR7B745 HE Manufacturing
Open in API
Filings indexed 1,138 across all filing types
Latest filing 2026-03-31 Major Shareholding Noti…
Country FI Finland
Listing HE ORNAV

About Orion Oyj

https://www.orion.fi/en/

Orion Oyj is a globally operating pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients (APIs). The company's portfolio encompasses a wide range of products, including prescription drugs, generic medications, and over-the-counter (OTC) products. In addition to its proprietary and generic product lines for both human and animal health, Orion provides contract manufacturing and packaging services to other pharmaceutical entities. The company manages the entire pharmaceutical value chain, from research and development through to production and marketing.

Recent filings

Filing Released Lang Actions
Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
Major Shareholding Notification Classification · 99% confidence The document is a statutory notification under Finnish securities law (“Arvopaperimarkkinalain 9. luvun 10. pykälä”) indicating that BlackRock, Inc. and its funds have crossed the 5% ownership threshold in Orion Oyj. It details share counts and percentages pre- and post-threshold. This matches the definition of a Major Shareholding Notification (Code: MRQ).
2026-03-31 Finnish
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Major Shareholding Notification Classification · 96% confidence The document is a stock exchange release under the Securities Market Act disclosing that BlackRock, Inc. has crossed the 5% ownership threshold in Orion Corporation. It provides details of the shareholding and voting rights positions before and after crossing the threshold. This is a classic major shareholding notification (threshold crossing report), matching our “Major Shareholding Notification” category.
2026-03-31 English
Orion Oyj: Johtohenkilöiden liiketoimet - René Lindell
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction in company shares by a person discharging managerial responsibilities (René Lindell, CFO of Orion Oyj). It explicitly references the EU Market Abuse Regulation (MAR) and provides details such as the transaction date, instrument type (shares), and the nature of the transaction (receipt of share-based incentive). This fits the definition of a Director's Dealing (DIRS) filing.
2026-03-10 Finnish
Orion Corporation: Managers' transactions - René Lindell
Director's Dealing Classification · 100% confidence The document is a formal notification of a manager's transaction involving Orion Corporation's CFO, René Lindell. It explicitly references the Market Abuse Regulation (EU) No 596/2014 and provides specific details regarding the receipt of share-based incentives, including the person's name, position, transaction date, and volume. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2026-03-10 English
Orion Oyj: Johtohenkilöiden liiketoimet - Mikko Kemppainen
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically Mikko Kemppainen, regarding the receipt of share-based compensation. The text explicitly references the EU Market Abuse Regulation (MAR) No 596/2014, which is the standard regulatory framework for reporting director and executive dealings. This falls directly under the 'Director's Dealing' category.
2026-03-10 Finnish
Orion Corporation: Managers' transactions - Mikko Kemppainen
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction involving a manager (Mikko Kemppainen) of Orion Corporation. It explicitly cites the Market Abuse Regulation (EU) No 596/2014 and provides specific details regarding the nature of the transaction (receipt of a share-based incentive), the volume, and the date. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing, which covers personal share transactions by company directors and executives.
2026-03-10 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.